Correlation Between Biotron and Ascletis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotron and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotron and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotron Limited and Ascletis Pharma, you can compare the effects of market volatilities on Biotron and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotron with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotron and Ascletis Pharma.

Diversification Opportunities for Biotron and Ascletis Pharma

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Biotron and Ascletis is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Biotron Limited and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Biotron is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotron Limited are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Biotron i.e., Biotron and Ascletis Pharma go up and down completely randomly.

Pair Corralation between Biotron and Ascletis Pharma

Assuming the 90 days horizon Biotron Limited is expected to generate 5.76 times more return on investment than Ascletis Pharma. However, Biotron is 5.76 times more volatile than Ascletis Pharma. It trades about 0.04 of its potential returns per unit of risk. Ascletis Pharma is currently generating about 0.01 per unit of risk. If you would invest  5.67  in Biotron Limited on November 4, 2024 and sell it today you would lose (0.70) from holding Biotron Limited or give up 12.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Biotron Limited  vs.  Ascletis Pharma

 Performance 
       Timeline  
Biotron Limited 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Biotron Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Biotron reported solid returns over the last few months and may actually be approaching a breakup point.
Ascletis Pharma 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Biotron and Ascletis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotron and Ascletis Pharma

The main advantage of trading using opposite Biotron and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotron position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.
The idea behind Biotron Limited and Ascletis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance